Partnership Opportunities

Join the Program as a Virtual Partner

Partner with the only cell type agnostic, targeting focused cell therapy meeting

The 2nd Multi-Functional Cell Therapies Summit provides an exclusive insight into the next generation of cell therapy development spanning across the development stage pipeline. As large pharma and smaller biotech alike work
to address complex engineering challenges, design targeting strategies and progress their therapies into the clinic, these global leaders are looking for innovative services and solutions to advance their development.

This is your unique opportunity to establish long-term partnerships and secure new business as the cell therapy space turns its focus to this next generation. Join the conversation with C-Level Executives, VPs and Directors to establish yourself as a partner:

MFCT Bullet

Progress multi-omics and analytical development to characterize next-generation therapies and signal integration

MFCT Bullet

Advance cell engineering to achieve higher payload capacity whilst maintaining quality and persistence

MFCT Bullet

Support pre-clinical research efforts with target identification, validation, assay development and antibody production

MFCT Bullet

Share insights and thought leadership to address regulatory challenges and progress complex engineered and combination therapies to the clinic

4 Key Reasons to Partner:


Generate new business leads by securing invaluable connections with key decision makers through structured networking and preorganized 1-2-1 meetings

Capture-modified (1)

Showcase your capabilities by positioning your product to C-Suite Executives, Vice Presidents & Directors at both Big Pharma companies and the innovative biotechs leading the way in cell therapy development

Capture-modified (2)

Build your network with the key decision makers and pioneers in this fast developing field, to form long-lasting business relationships as the industry takes new heights

Capture-modified (3)

Share your insights and thought leadership to help drug developers overcome clinical operations, manufacturing and regulatory challenges and progress multi functional cell therapies to the clinic